The Trump administration announced Friday that it is not moving forward with a Biden-era proposal that would have expanded ...

In November last year, the Biden administration proposed a new rule that would allow drugs like Wegovy and Zepbound to be ...

President Donald Trump’s administration has decided not to cover expensive, high-demand obesity treatments under the ...

The Trump administration on Friday scrapped a Biden administration proposal to have Medicare cover anti-obesity drugs, ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Trump officials reject Medicare coverage ...

Health and Human Services Secretary Robert F. Kennedy Jr. has been critical of the drugs, instead placing a focus on ...

The Centers for Medicare and Medicaid Services (CMS) finalized a Medicare Advantage (MA) rule proposed by the Biden ...

Trump administration rejects a Biden plan to expand Medicare coverage of weight-loss drugs such as Zepbound and Wegovy.

The rise of GLP-1 drugs like Ozempic are changing consumer food waste patterns both at home and in restaurant settings.

More than 7 million people would have gained coverage to the medicine, CMS said when it proposed the rule.

The Trump administration has decided against implementing a proposal for Medicare and Medicaid to cover weight loss drugs, the Centers for Medicare and Medicaid Services said in a filing published ...

Whether or not you choose to cover weight loss drugs, offering holistic support can make a meaningful difference in employee ...